Rybelsus emerged from the scientific breakthrough of GLP-1 receptor agonists, revolutionizing how people manage type 2 diabetes. Unlike traditional diabetes medications, Rybelsus operates through a unique biochemical pathway. It mimics the action of incretin hormones, which play a vital role in glucose metabolism. By binding to GLP-1 receptors, Rybelsus stimulates…